SNPwatch gives you the latest news about research linking various traits and conditions to individual genetic variations. These studies are exciting because they offer a glimpse into how genetics may affect our bodies and health; but in most cases, more work is needed before this research can provide information of value to individuals. For that reason it is important to remember that like all information we provide, the studies we describe in SNPwatch are for research and educational purposes only. SNPwatch is not intended to be a substitute for professional medical advice; you should always seek the advice of your physician or other appropriate healthcare professional with any questions you may have regarding diagnosis, cure, treatment or prevention of any disease or other medical condition.Nature Genetics, may help scientists understand more about the how hepatitis B causes disease and could someday facilitate the development of new treatments.Researchers analyzed the DNA of more than 2,000 people with chronic hepatitis B and more than 4,000 controls from Japan and Thailand. Two genetic variations, SNPs rs3077 and rs9277535, showed significant associations with the condition. For both, each copy of an A reduced the odds of chronic hepatitis B infection by about 40%.The researchers note that the protective A versions of rs3077 and rs9277535 tend to be found at lower frequencies in areas with high rates of chronic hepatitis B. While the scientists don’t contend that genetic factors are the sole determinants of disease prevalence, they do suggest that these factors might exert a substantial influence.(The relationship is strongest for rs3077 – see graphics at the end of this post. 23andMe customers can check their data for rs3077 and rs9277535 using the Browse Raw Data feature.)The genes in closest proximity to the two identified SNPs, HLA-DPA1 and HLA-DPB1, encode subunits of an immune system protein called HLA-DP. Upon further analysis, the researchers found that variations in the HLA-DPA1 and HLA-DPB1 genes also affect the odds of chronic hepatitis B infection.HLA-DP is one of several proteins that help alert the immune system to the presence of infections. The authors of the study suggest that changes in this protein might affect its ability to signal the immune system and could therefore result in a weak, or even completely absent, immune response to hepatitis B infection. This, in turn, could lead to persistent infection with the virus. In support of this idea, previous research has shown that some versions of the HLA-DPA1 and HLA-DPB1 genes affect the immune system’s response to the hepatitis B vaccine.Map Image: PhillipN
- Box size is relative to chronic hepatitis infection rate. Rates were determined by taking the average of the rates given by the authors of this study for each population. These are only estimates.
- Color indicates the frequency of the A version of rs3077 or rs9277535. Lighter colors indicate lower frequencies.
- Populations are broad categories: Asian, African, European, Central American
- Subpopulations are HapMap3 populations
- Information can be recategorized by changing order of the population and subpopulation icons at the top of the graphic.